Detailed View
ORKA - Oruka Therapeutics, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
2,021,085,440
Adj EBIT (TTM)
-122,051,000
Enterprise Value
1,684,041,440
Last Price
41.75
Earnings Yield
-7.25%
Return on Capital
-25.79%
Capital
473,243,000
1Y Price Chart
Last Price: $41.75
1Y Change: 276.47%
As of 2026-03-16 | 1Y Change: 276.47%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -9,345,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -34,105,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -53,515,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -25,086,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -24,714,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -57,805,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -3,122,000 |
| 2024-03-31 | 10-Q | 2024 | 0 | -2,482,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.